News & Updates
Filter by Specialty:
Maintenance olaparib confers survival benefit for HRD+ ovarian cancer patients
In the final overall survival (OS) analysis of the phase III PAOLA-1*/ENGOT-ov25 trial, the addition of olaparib to bevacizumab provided a survival benefit for women with newly diagnosed advanced ovarian cancer with HRD**-positive (HRD+) tumours.
Maintenance olaparib confers survival benefit for HRD+ ovarian cancer patients
19 Dec 2022Gestational diabetes mellitus predisposes women to prediabetes, T2DM
Among women with a history of gestational diabetes mellitus (GDM), the conversion to prediabetes or type 2 diabetes mellitus (T2DM) appears to be high, a recent study has found.
Gestational diabetes mellitus predisposes women to prediabetes, T2DM
19 Dec 2022Cervical cancer screening: Thumbs up for HPV self-sampling among women in SG
Human papillomavirus (HPV) self-sampling for cervical cancer screening is highly acceptable among Singaporean women, with the strategy deemed accurate and easy to perform, a study has found.
Cervical cancer screening: Thumbs up for HPV self-sampling among women in SG
16 Dec 2022Pregnant women in ICU for COVID-19 more deprived, less vaccinated
Pregnant or recently pregnant women who needed intensive care admission due to COVID-19 tend to live in poorer areas and are less likely to have been vaccinated, a recent study has found.
Pregnant women in ICU for COVID-19 more deprived, less vaccinated
12 Dec 2022Progestin shows therapeutic potential in PR-positive endometrial cancer
Progestin therapy appears to yield high response rates in advanced stage and recurrent endometrial cancer that is positive for progesterone receptor (PR) expression, while having low toxicity, according to a study.
Progestin shows therapeutic potential in PR-positive endometrial cancer
08 Dec 2022Coffee intake lowers risk of endometrial cancer
Women who love to drink coffee will have more reason to do so following a study that reports an association between coffee consumption and a reduced risk of endometrial cancer, particularly among those with higher body mass index (BMI).